Navigation Links
With Economic Pain Contributing to Minor Strains and Sprains, King Pharmaceuticals(R), Inc. and RealAge.com Launch Effort to Educate Americans on Prevention and Treatment
Date:9/21/2009

ormal activities before the injury is properly healed increases the chances of reinjury and can lead to a chronic problem.(3)

"Because strains and sprains are common, people can underestimate their possible long-term effects, especially if not properly treated," said Dr Bruce Thomas, Medical Director for the Ladies Professional Golf Association and Assistant Professor of Sports Medicine/Family Practice at Florida State University. "When in doubt, patients should always contact a healthcare professional for advice. Treatment for minor strains and sprains may include rest, ice, and nonsteroidal anti-inflammatory drugs (NSAIDs) either orally or in a topical patch, such as FLECTOR(R) Patch (diclofenac epolamine topical patch) 1.3%, which delivers an NSAID directly to the site of acute (short-term)pain."(3)

King Pharmaceuticals markets FLECTOR(R) Patch (diclofenac epolamine topical patch) 1.3%, the first and only prescription acute pain relief patch available in the United States that contains an NSAID.(4,5) The patch is used for the topical treatment of acute (short-term) pain due to minor strains, sprains, and contusions (bruises).(4)

About FLECTOR(R) Patch

Each FLECTOR(R) Patch contains 180 mg of diclofenac epolamine, an NSAID, the same class of drugs that includes ibuprofen and naproxen. These drugs relieve pain. FLECTOR(R) Patch releases its active ingredient locally through the skin at the site of acute pain. The medication in pills or capsules, which are taken by mouth, is absorbed through the stomach and digestive tract and then spread throughout the body.

FLECTOR(R) Patch (diclofenac epolamine topical patch) 1.3% is used for the topical treatment of acute (short-term) pain due to minor strains, sprains, and contusions (bruises).

FLECTOR(R) Patch is a nonsteroidal anti-inflammatory drug (NSAID). Use FLECTOR(R) Patch exactly as your healt
'/>"/>

SOURCE RealAge.com
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says
2. Economic Pressures Turning Companies to Supply Chains for Revenue Gains and Cost Savings
3. Economic Conditions Signal Long-Term Shift in Rx Benefit Approach
4. Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program
5. Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program
6. New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall
7. 2nd Quarter Snapshot Survey: The Personal Pain of Economic Disaster
8. BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn
9. New Analysis: Women of Low Socio-Economic Status Face Unique Challenges Related to Smoking, Smoking Ban Policies
10. Increasing Regulation and Economic Volatility Key Catalysts for Risk Management in the Food System, Agribusiness and Beverage Industry, Says Report from Aon Analytics
11. Healthcare: Solutions for the American Crisis The Economic Report Show to Feature Rising Medical Solutions, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... As a result of C3: Colorectal Cancer Coalition,s advocacy ... research program is included in the final Fiscal Year ... research program will research cancers, like colorectal cancer, that ... ovarian cancer research programs run by the U.S. Army ... $15 million in funding for this new cancer research ...
(Date:12/16/2009)... Institute announce the first comprehensive analyses of cancer genomes. ... the DNA of cancer cells which are acquired during ... and a lung cancer, reveal for the first time ... cancers. , Lung cancer causes around one million deaths ... The number of mutations found suggest that a typical ...
(Date:12/16/2009)... Cost-Effective Care , ... Washington, D.C. (Vocus) December 16, ... ways to rein in runaway costs while providing care to all ... the ongoing discussion includes how to ensure patients equal access to ... (MDs) or osteopathy (DOs). In both the House and Senate ...
(Date:12/16/2009)... through annual marketing campaign , ... ... 2010 Genetown™ Hotbed Campaign as its largest yearly ... sponsored by MassBio and showcases 37 Massachusetts companies ... each entity’s brand on an electronic and printed map ...
(Date:12/16/2009)... Inc., developers of the AcceleDent System , ... announced Alison Davies as its new Director of ... spent the last fourteen years of her professional ... nine years as a senior manager with ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO ) ,, ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4
... room, The Flag Company, Inc.,s new ,Feel Good, Light Lenses are ... during this trying economical time. , ... (PRWEB) March ... has gripped the nation, the Flag Company, Inc. recently launched ,Feel ...
... at the KK Women,s and Children,s Hospital (KKH) can now opt ... an anesthetic-free yet almost painless operation to treat uterine fibroids. ... ... at the KK Women,s and Children,s Hospital (KKH) can ...
... the first in a series of residential vacuum cleaner reviews conducted in ... ... Idaho (Vocus) March 3, 2009 -- Before spending hundreds of dollars on ... savvy shoppers turn to the Internet to research their choices. , , ...
... March 3 Based on its recent analysis ... Sullivan recognizes Aesku.Diagnostics with the 2008 European Frost ... consistent approach towards product development. It has anticipated ... offered versatile immunoassay systems, extended research capabilities as ...
... /PRNewswire/ -- ... a division of United Business Media Limited, has signed ... to provide an integrated medicine management system for two ... Data Solutions are already used in approximately 700 hospitals ...
... The southeast Pacific nation of Papua New Guinea, home ... Earth, has created its first national conservation area to ... than Singapore. , The decision by the Papua New ... the newly established YUS Conservation Area, results from more ...
Other Medicine News:Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 3Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 2Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 3Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 4Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 2Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 3Health News:Frost & Sullivan Lauds Aesku.Diagnostics For Providing an Overall Analysis Platform For a Wide Range of Autoimmune Complications 2Health News:Frost & Sullivan Lauds Aesku.Diagnostics For Providing an Overall Analysis Platform For a Wide Range of Autoimmune Complications 3Health News:Frost & Sullivan Lauds Aesku.Diagnostics For Providing an Overall Analysis Platform For a Wide Range of Autoimmune Complications 4Health News:CMPMedica Signs an Agreement With MAIDIS for e-prescribing Solutions in Abu Dhabi (UAE) 2Health News:CMPMedica Signs an Agreement With MAIDIS for e-prescribing Solutions in Abu Dhabi (UAE) 3Health News:Papua New Guinea declares first national conservation area 2Health News:Papua New Guinea declares first national conservation area 3Health News:Papua New Guinea declares first national conservation area 4
(Date:12/16/2009)... Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: ... 2010 the U.S. Food and Drug Administration,s ... the New Drug Application (NDA) for pixantrone ... lymphoma (NHL). ODAC is an independent panel ... efficacy and safety of marketed and investigational ...
(Date:12/16/2009)... Today, a group of national medical societies ... 3590, the Patient Protection and Affordable Care Act, currently ... way towards a final vote in the coming days. ... to vote against a health care bill that is ... hand that our health care system needs reform - ...
(Date:12/16/2009)... , Dec. 16 MedSolutions ( ... management services, today commended two new studies highlighting ... scans and other diagnostic imaging tests. ,, ... proper diagnosis and treatment," said Gregg Allen, M.D., ... studies offer more compelling evidence that stricter quality ...
Breaking Medicine Technology:Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4Physician Groups Oppose Current Senate Health Care Reform Bill 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 4671 1PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 4671 2Pennsylvania Department of Health Workshops Will Help Businesses Prepare for Flu Pandemic 50436 1Pennsylvania Department of Health Workshops Will Help Businesses Prepare for Flu Pandemic 50436 2Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 1Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 2Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 3Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 4Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 5
For use with catalog #0454....
Determination of FDP in Plasma by Latex Agglutination, 60 tests.Microlatex particles coated with mouse monoclonal anti-human FDP antibodies....
Lupus Anticoagulant-Sensitive APTT Reagent.Cephalin with particulate activator (silica), freeze-dried....
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasmawith heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all free...
Medicine Products: